Disclosure Requirements | Description | |
1. | Information about the Significance of Financial Instruments for Financial Position and Performance | |
1.1 | Statement of Financial Position | |
1.1.1 |
Disclosures on categories of financial assets and financial liabilities. |
Notes to the financial statements:
Note 25 – Classification of financial assets and financial liabilities |
1.1.2 | Other Disclosures | |
i. Special disclosures about financial assets and financial liabilities designated to be measured at fair value through profit or loss, including disclosures about credit risk and market risk, changes in fair values attributable to these risks and the methods of measurement. |
Not designated Principal accounting policies:
Note 5.3.9 – Designation at fair value through profit or loss Notes to the financial statements: Note 08 – Financial risk review |
|
ii. Reclassifications of financial instruments from |
Principal accounting policies: Note 5.3.3 – Reclassification of financial assets | |
iii. Information about financial assets pledged as collateral and about financial or non–financial assets held as collateral. |
Notes to the financial statements: Note 45.1 – Assets pledged as security | |
iv. Reconciliation of the allowance account for |
Note the financial statements: Note 31.1.4 – Movement in impairment during the year | |
v. Information about compound financial |
The Bank does not have compound financial instruments with multiple embedded derivatives | |
vi. Breaches of terms of loan agreements. |
None | |
1.2 | Statement of Comprehensive Income | |
1.2.1 |
Disclosures on items of income, expense, gains and losses. |
Notes to the financial statements: Notes 10 to 23 |
1.2.2 | Other Disclosures | |
i. Total interest income and total interest expense |
Notes to the financial statements: Note 11 – Net interest income | |
ii. Fee income and expense. |
Notes to the financial statements: Note 12 – Net fee and commission income | |
iii. Amount of impairment losses by class of |
Notes to the financial statements: Note 17 – Impairment for loans and other losses | |
iv. Interest income on impaired financial assets. |
The Bank has discontinued the recognition of interest income on impaired financial assets as given in Note 11 – Net interest income |
|
1.3 | Other Disclosures | Principal accounting policies: |
1.3.1 | Accounting policies for financial instruments. | Note 5.3 – Financial assets and Financial liabilities |
1.3.2 | Information on hedge accounting. | Notes to the financial statements: Note 29 – Derivative financial assets/liabilities |
1.3.3 | Information about the fair values of each class of financial asset and financial liability, along with: | |
i. Comparable carrying amounts. |
Notes the financial statements: Notes 9.1 to 9.4.8 – Fair values of financial instruments | |
ii. Description of how fair value was determined. |
Notes to the financial statements: Note 9 – Fair values of financial instruments | |
iii. The level of inputs used in determining fair value. |
Notes to the financial statements: Notes 9.1 – Valuation models | |
iv. a. Reconciliations of movements between levels b. Additional disclosures for financial instruments |
There were no movements between level of fair value hierarchy during the year under review |
|
v. Information if fair value cannot be reliably measured. |
Notes to the financial statements: Notes 9.4.1 to 9.4.8 | |
2. |
Information about the Nature and Extent of Risks Arising from Financial Instruments |
|
2.1 | Qualitative Disclosures | |
2.1.1 | Risk exposures for each type of financial instrument. | Notes to the financial statements: Note 8 – Financial risk review |
2.1.2 | Management’s objectives, policies, and processes for managing those risks. | Notes to the financial statements: Note 8 – Financial risk review |
2.1.3 | Changes from the prior period. | Notes to the financial statements: Note 61 – Comparative figures |
2.2 | Quantitative Disclosures | |
2.2.1 | Summary of quantitative data about exposure to each risk at the reporting date. | Notes to the financial statements: Note 8 – Financial risk review |
2.2.2 | Disclosures about credit risk, liquidity risk, market risk, operational risk, interest rate risk and how these risks are managed. | |
i. Credit Risk | ||
a. Maximum amount of exposure (before deducting the value of collateral), description of collateral, information about credit quality of financial assets that are neither past due nor impaired |
Notes to financial statements: Note 8.2.3 – Credit quality analysis Note 8.2.4 – Collateral held and other credit enhancement | |
b. For financial assets that are past due or impaired, disclosures on age, factors considered in determining as impaired and the description |
Notes to the financial statements: Note 8.2.3 – Credit quality analysis Note 8.2.4 – Collateral held and other credit enhancement Note 8.2.5 – Amounts arising from ECL | |
c. Information about collateral or other credit enhancements obtained or called. |
Notes to the financial statements: Note 8.2.4 – Collateral held and other credit enhancement | |
d. For other disclosures, please refer Banking |
Notes to the financial statements: Note 8.2 – Credit risk (Financial risk review) | |
ii. Liquidity Risk | ||
a. A maturity analysis of financial liabilities. |
Notes to the financial statements: Notes 8.3.3 – Maturity analysis of financial liabilities and financial assets | |
b. Description of approach to risk management. |
Notes to the financial statements: Note 8 – Financial risk review | |
c. For other disclosures, please refer Banking Act Direction No. 7 of 2011 on Integrated Risk Management Framework for Licensed Banks (Section H). |
Notes to the financial statements: Note 8.3 – Liquidity risk (Financial risk review) | |
iii. Market Risk | ||
a. A sensitivity analysis of each type of market risk to which the entity is exposed. |
Notes to the financial statements: Note 8.4 – Market risk financial risk review) | |
b. Additional information, if the sensitivity analysis is not representative of the entity’s risk exposure. |
None | |
c. For other disclosures, please refer Banking Act Direction No. 7 of 2011 on Integrated Risk Management Framework for Licensed Banks (Section H). |
Notes to the financial statements: Note 8.4 – Market risk financial risk review) | |
iv. Operational Risk | ||
Please refer Banking Act Direction No. 7 of 2011 on Integrated Risk Management Framework for Licensed Banks (Section H). | Notes to the financial statements: Note 8.5 – Operational risk financial risk review) | |
v. Equity Risk in the Banking Book | ||
a. Qualitative Disclosures | ||
|
Notes to the financial statements: Note 8.4.2.1 – Equity price risk | |
|
Note 5.1.1 to 5.1.7 – Basis of consolidation Note 34 – Investments in subsidiaries Note 35 – Investments in associates Note 36 – Investments in joint venture | |
b. Quantitative Disclosures | ||
|
Notes to the financial statements: Note 30 – Financial assets measured at fair value through profit or loss Note 33 – Financial assets measured at fair value through other comprehensive income | |
|
Notes to the financial statements: Note 13 – Net (loss)/gain from trading Note 15 – Net gains from derecognition of financial assets Note 16 – Net other operating income | |
vi. Interest Rate Risk in the Banking Book | ||
a. Qualitative Disclosures | Notes to the financial statements: Note 8 – Financial risk review | |
|
||
b. Quantitative Disclosures |
Notes to the financial statements:
Note 8 – Financial risk review
Note 8.4.4.1 – Potential impact on NII due to change in market interest rates |
|
|
||
2.2.3 | Information on concentrations of risk. | Notes to the financial statements: Note 8 – Financial risk review |
3. | Other Disclosures | |
3.1 | Capital | |
3.1.1 | Capital Structure | |
i. Qualitative Disclosures. |
Notes to the financial statements: Note 8.6.1 – Key regulatory ratios – capital adequacy | |
Summary information on the terms and conditions of the main features of all capital instruments, especially in the case of innovative, complex or hybrid capital instruments. |
||
ii. Quantitative Disclosure | Notes to the financial statements: Note 8.6.1 – Key regulatory ratios – capital adequacy | |
a. The amount of Tier 1 capital, with separate disclosure of:
|
||
3.1.2 | Capital adequacy | |
i. Qualitative Disclosures |
Notes to the financial statements: Note 8.6 – Capital management | |
A summary discussion of the Bank’s approach to |
||
ii. Quantitative Disclosures |
||
a. Capital requirements for credit risk, market risk and operational risk |
Notes to the financial statements: Note 8.6 – Capital management | |
b. Total and Tier 1 capital ratio | Notes to the financial statements: Note 8.6.1 – Key regulatory ratios – capital adequacy |